Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jun 20, 2014

Biotechnology Venture Capital Surge Could Help Aching Pipelines

Noticeable product improvements may be on the way thanks to the deep pockets of VC firms.

Biotechnology Venture Capital Surge Could Help Aching Pipelines

According to the MoneyTree Report, biotechnology was the second largest investment area for venture capitalists. [© Bobby4237 - Fotolia.com]

  • Top pharmaceuticals face a dilemma in that many blockbuster drugs are losing patent protection and existing pipelines may not compensate for lost revenues. The ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »